Wednesday, Apr 24, 2024 | Last Update : 09:36 PM IST
Alhydroxiquim
Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response
Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India
05 Oct 2020 2:02 PM
1 of 1
ADVERTISEMENT
ADVERTISEMENT
more
Columns
Modi's "Guarantee 2024" vs Congress' "Nyay Patra" - A Clash of Narratives
Exploring the historical context and implications of the term "Hindu Rashtra" in light of constitutional and legal frameworks.
The BJP adapts its messaging, responding to opposition criticism with new assurances and clarifications.
Pradeep S. Mehta and T.B. Simi
Pradeep S. Mehta and Simi T.B. | Urgent action is required at all levels to tackle plastic pollution
Urgent Call to Action: Addressing the Global Plastic Pollution Crisis on Earth Day 2024